|
1.
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar
|
|
2.
|
Muller A, Homey B, Soto H, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Burger JA and Kipps TJ: CXCR4: a key
receptor in the crosstalk between tumor cells and their
microenvironment. Blood. 107:1761–1767. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Schimanski CC, Schwald S, Simiantonaki N,
et al: Effect of chemokine receptors CXCR4 and CCR7 on the
metastatic behavior of human colorectal cancer. Clin Cancer Res.
11:1743–1750. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Schimanski CC, Bahre R, Gockel I, et al:
Dissemination of hepatocellular carcinoma is mediated via chemokine
receptor CXCR4. Br J Cancer. 95:210–217. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Jiang YP, Wu XH, Shi B, Wu WX and Yin GR:
Expression of chemokine CXCL12 and its receptor CXCR4 in human
epithelial ovarian cancer: an independent prognostic factor for
tumor progression. Gynecol Oncol. 103:226–233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Wang L, Wang L, Yang B, et al: Strong
expression of chemokine receptor CXCR4 by renal cell carcinoma
cells correlates with metastasis. Clin Exp Metastasis.
26:1049–1054. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Devarajan E and Huang S: STAT3 as a
central regulator of tumor metastases. Curr Mol Med. 9:626–633.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Yu H and Jove R: The STATs of cancer – new
molecular targets come of age. Nat Rev Cancer. 4:97–105. 2004.
|
|
10.
|
Hsieh FC, Cheng G and Lin J: Evaluation of
potential Stat3-regulated genes in human breast cancer. Biochem
Biophys Res Commun. 335:292–299. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Yasumitsu A, Tabata C, Tabata R and
Hirayama N: Clinical significance of serum vascular endothelial
growth factor in malignant pleural mesothelioma. J Thorac Oncol.
5:479–483. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Huang C, Yang G, Jiang T, Huang K, Cao J
and Qiu Z: Effects of IL-6 and AG490 on regulation of Stat3
signaling pathway and invasion of human pancreatic cancer cells in
vitro. J Exp Clin Cancer Res. 29:512010. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Cascio S, Ferla R, D’Andrea A, Gerbino A,
Bazan V, Surmacz E and Russo A: Expression of angiogenic
regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3
pathway in colorectal cancer cells. J Cell Physiol. 221:189–194.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Balkwill F: Cancer and the chemokine
network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar
|
|
15.
|
Kim J, Takeuchi H, Lam ST, et al:
Chemokine receptor CXCR4 expression in colorectal cancer patients
increases the risk for recurrence and for poor survival. J Clin
Oncol. 23:2744–2753. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Maréchal R, Demetter P, Nagy N, Berton A,
Decaestecker C, Polus M, Closset J, Devière J, Salmon I and van
Laethem JL: High expression of CXCR4 may predict poor survival in
resected pancreatic adenocarcinoma. Br J Cancer. 100:1444–1451.
2009.PubMed/NCBI
|
|
17.
|
Oda Y, Tateishi N, Matono H, Matsuura S,
Yamamaoto H, Tamiya S, Yokoyama R, Matsuda S, Iwamoto Y and
Tsuneyoshi M: Chemokine receptor CXCR4 expression is correlated
with VEGF expression and poor survival in soft-tissue sarcoma. Int
J Cancer. 124:1852–1859. 2009.PubMed/NCBI
|
|
18.
|
Lapteva N, Yang AG, Sanders DE, Strube RW
and Chen SY: CXCR4 knockdown by small interfering RNA abrogates
breast tumor growth in vivo. Cancer Gene Ther. 12:84–89. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Burger JA and Stewart DJ: CXCR4 chemokine
receptor antagonists: perspectives in SCLC. Expert Opin Investig
Drugs. 18:481–490. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Na IK, Scheibenbogen C, Adam C, Stroux A,
Ghadjar P, Thiel E, Keilholz U and Coupland SE: Nuclear expression
of CXCR4 in tumor cells of non-small cell lung cancer is correlated
with lymph node metastasis. Hum Pathol. 39:1751–1755. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Bromberg J: Stat proteins and oncogenesis.
J Clin Invest. 109:1139–1142. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Zaid Al, Siddiquee K and Turkson J: STAT3
as a target for inducing apoptosis in solid and hematological
tumors. Cell Res. 18:254–267. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Garcia R, Bowman TL, Niu G, et al:
Constitutive activation of Stat3 by the Src and JAK tyrosine
kinases participates in growth regulation of human breast carcinoma
cells. Oncogene. 20:2499–2513. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Barbieri I, Pensa S, Pannellini T, et al:
Constitutively active Stat3 enhances neu-mediated migration and
metastasis in mammary tumors via upregulation of Cten. Cancer Res.
70:2558–2567. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Song L, Turkson J, Karras JG, Jove R and
Haura EB: Activation of STAT-3 by receptor tyrosine kinases and
cytokines regulates survival in human non-small cell carcinoma
cells. Oncogene. 22:4150–4165. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Li GH, Wei H, Lv SQ, Ji H and Wang DL:
Knockdown of STAT3 expression by RNAi suppresses growth and induces
apoptosis and differentiation in glioblastoma stem cells. Int J
Oncol. 37:103–110. 2010.PubMed/NCBI
|
|
27.
|
Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F,
Sawaya R and Huang S: Stat3 activation regulates the expression of
matrix metalloproteinase-2 and tumor invasion and metastasis.
Oncogene. 23:3550–3560. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Qu P, Roberts J, Li Y, et al: Stat3
downstream genes serve as biomarkers in human lung carcinomas and
chronic obstructive pulmonary disease. Lung Cancer. 63:341–347.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Kim HS, Park YH, Lee J, et al: Clinical
impact of phosphorylated signal transducer and activator of
transcription 3, epidermal growth factor receptor, p53, and
vascular endothelial growth factor receptor 1 expression in
resected adenocarcinoma of lung by using tissue microarray. Cancer.
116:676–685. 2010. View Article : Google Scholar
|
|
30.
|
Dassoulas K, Gazouli M, Theodoropoulos G,
et al: Vascular endothelial growth factor and endoglin expression
in colorectal cancer. J Cancer Res Clin Oncol. 136:703–708. 2010.
View Article : Google Scholar : PubMed/NCBI
|
